The National Agency for Food and Drug Administration and Control (NAFDAC) in efforts to curb the spread of the COVID-19 pandemic has granted conditional approval for emergency purposes to the Janssen COVID-19 vaccine produced by the Johnson&Johnson (J&J) medical device company. In a statement on Tuesday in Abuja, the Director-General, NAFDAC, Dr.Mojisola Adeyeye said the approval for the Janssen vaccine was done “after a thorough evaluation” of the product, adding that the agency’s vaccine committee “concluded that the data on the vaccine were robust and met criteria for efficacy, safety and quality”.